Sandoz completed its long-heralded separation from Novartis on schedule this morning, with its shares trading at CHF 24 on the SIX Swiss Exchange. That valued the newly independent company at CHF ...

Eli Lilly's lepodisiran has been shown to reduce Lp (a) levels by more than 90% for at least six months with a single injection in a phase 2 trial.